Melissa Usoz, MS, BS

Prisma Health Cancer Institute
Greenville, SC

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 3303 - Treatment Outcomes with Neoadjuvant Chemotherapy Followed by Chemoradiation for Muscle Invasive Bladder Cancer

  Tuesday, October 1, 2024
  2:30 PM – 3:45 PM ET